Specifically, we saw that both the amount of communication from tumor to CD8 (arc average 0.0292 before treatment vs. 0.0450 on treatment, respectively) and from Ms to CD8 (0.0155 vs. 0.0317, respectively) doubled. Here, CD8A is linked to neoplasm.